Radiopharmaceutical Dosimetry

Dosimetry in Radiopharmaceuticals

Navigating the Future of Cancer Treatment

Navigating the Future of Cancer Treatment

Radiopharmaceutical Dosimetry
Leading the Industry in Dosimetry

Dosimetry for radiopharmaceutical trials

As interest in radiopharmaceutical therapies (RPT) dramatically grows, particularly in terms of a theranostics paradigm that combines diagnosis and therapy, there is major need for an individualized radiation dosimetry methodology tailored to the needs of RPT clinical trials. The aim of radiation dosimetry in RPT trials is to estimate the absorbed doses to healthy tissues (toxicity) and tumor lesions (efficacy) after administration of a therapeutic dose, and help identifying the optimal dose in Phase I trials.  

Direct imaging of radionuclides and their decay chains at optimized time points enables the accurate quantification of the radiopharmaceutical’s time-dependent uptake, biodistribution and clearance. This facilitates the integration of measured time–activity data and computation of organ and lesion absorbed dose coefficients (i.e., absorbed doses per unit administered activity). With emerging alpha-emitting radiopharmaceuticals, direct imaging can be challenging and requires optimized imaging acquisition and reconstruction protocols to allow for good signal and counting statistics in an acceptable total scan duration for study participants. Surrogate radionuclides (positron- or single-photon- emitters) may also be used as an alternative way to estimate therapeutic absorbed doses, assuming similar pharmacokinetics and biodistribution in the theranostic pair.  

black male scientist on computer in lab

Leading cro in radiation & Radiopharmaceutical therapy

Innovative Dosimetry Solutions by Medpace

Medpace, a leading CRO working in radiopharmaceuticals with over 30 years of experience in oncologic therapeutic development, is at the forefront of advancing these dosimetric approaches to meet your RPT trial needs. Medpace’s standardized and validated methods, focus on data quality and operational excellence to ensure reliable results in the required timeframe. From reviewing patient eligibility where analysis speed is critical, to monitoring safety limits for single patients to support ongoing treatment, or combined analyses of multiple patients for safety oversight and study endpoints, Medpace delivers.  

Medpace Dosimetry Program for RPT

Medpace imaging specialists and medical physicists support the creation of imaging protocols, guide the choice of imaging modalities, streamline schedules, and determine the sampling time points needed to optimize dosimetry calculations. Our dosimetry expert team will customize the dosimetry methodology for each study and provide solid estimates of biodistribution and radiation absorbed doses to tumor lesions and organs of interest. 

When you partner with Medpace, your RPT program will benefit from:  

  • Expert guidance on protocol, imaging acquisition, and analysis for dosimetry 
  • Expertise with diagnostic, therapy, and theragnostics  
  • Standardized workflow with rigorous documentation and manuals  
  • Customizable data deliverables  
  • Reviewing of clinical relevance by ABR certified radiation oncologists  
DNA design

“Always aligned with our Sponsor’s goals, we make sure that trials are poised to enroll quickly, treat patients safely, and eliminate unnecessary redundancies.”

Blythe Thomson, MD
Senior Vice President, Medical Department,
Hematology & Oncology

Medpace Core Labs Offering for Quantitative Imaging and Dosimetry

Medpace Core Labs is dedicated to providing comprehensive services for quantitative imaging, radioactive PK and dosimetry, ensuring the highest standards in accuracy and quality. Services include:

Checking magnetic resonance image (MRI)

Integrated Expertise in Dosimetry

Integrate dosimetry seamlessly into your study by combining the dosimetry expertise of Medpace Core Labs with the operational expertise of Medpace CRO study teams to manage your trial means complete efficiency in execution. With our integrated services and systems, we achieve higher levels of efficiency and productivity, from trial inception to completion. 

  • Our Medical team, Clinical Trial Managers, dosimetry experts and imaging technologists evaluate the protocol holistically to streamline study schedules and imaging protocols, ensuring protocols are appropriate for patients and sites whilst meeting the study endpoints
  • Clinical operations, Data Management and Medpace Core Lab (MCL) work in partnership to develop data capture systems which work in harmony, providing an optimal user experience for site staff and efficient, high quality data collection  
  • Throughout the trial, CRAs work seamlessly with Medpace Core Lab (MCL) imaging technologists to clean and verify data and provide ongoing site support  
  • Truly cross-functional and comprehensive site training and support from beginning to end

Related Resources